Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EVMN stock hub

Evommune, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EVMNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

825.5M

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

EVMN

In the news

Latest news · EVMN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-45

P25 -105.6P50 -46.5P75 -3.1

ROIC-32.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EVMN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002044725
Company name	Evommune, Inc.
Country	United States
Country code	US
Cusip	30054Y107
Employees	48
Enterprise value	$622.6M
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2025-11-06
Isin	US30054Y1073
Last refreshed	2026-05-10
Market cap	$825.5M
Market cap category	Small-Cap
Price	$22.92
Price currency	USD
Rev Per Employee	208,333.33x
Sector	Healthcare
Sic	2834
Symbol	EVMN
Tags	pharmaceuticals
Website	https://www.evommune.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.2%
EV/Sales	62.26x
FCF yield	-9.73%
P/B ratio	2.71x
P/S ratio	82.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$10M
Gross Profit Growth	233.33%
Net Income	$-76M
Net Income Growth Years	0%
Pretax Margin	-759.87%
Profit Per Employee	$-1.6M
ROA	-29.72
ROCE	-28.86
ROE	-44.95
ROIC	-32.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth	233.33x
Revenue Growth Years	2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.05
Assets	$322.5M
Cash	$211.5M
Current Assets	$215.9M
Current Liabilities	$10.6M
Debt	$8.6M
Debt Equity	$0.03
Equity	$304.6M
Interest Coverage	-12,856.1
Liabilities	$17.9M
Long Term Assets	$106.6M
Long Term Liabilities	$7.3M
Net Cash	$202.9M
Net Cash By Market Cap	$24.58
Net Cash Growth	328.66%
Net Debt Equity	$-0.67
Tangible Book Value	$304.6M
Tangible Book Value Per Share	$8.46

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	20.36
Net Working Capital	$-5M
Quick ratio	19.94
Working Capital	$205.3M
Working Capital Turnover	$0.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-829.54%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	24.63
All Time High	33.2
All Time High Change	-30.96%
All Time High Date	2026-02-10
All Time Low	13.89
All Time Low Change	65.07%
All Time Low Date	2025-12-18
ATR	1.9
Beta1y	0.09
Ch YTD	33.88
High	24.9
High52	33.2
High52 Date	2026-02-10
High52ch	-30.96%
Low	22.42
Low52	13.89
Low52 Date	2025-12-18
Low52ch	65.07%
Ma50ch	-6.94%
Premarket Change Percent	6
Premarket Price	$23.85
Premarket Volume	1,249
RSI	41.57
RSI Monthly	0
RSI Weekly	59.15
Sharpe ratio	0.73x
Sortino ratio	1.54
Total Return	-829.54%
Tr YTD	33.88
Tr1m	-7.54%
Tr1w	-6.45%
Tr3m	32.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	4
Analyst Price Target Top	$42
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.84
Earnings Revenue Estimate	1,299,296x
Operating Income	$-90M
Operating margin	-899.9
Price target	$43.88
Price Target Change	$91.45
Price Target Change Top	$83.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,596,685%
Float Percent	54.41%
Net Borrowing	-464,000
Shares Insiders	2.59%
Shares Institutions	40.07%
Shares Out	36,018,372
Shares Qo Q	70.26%
Shares Yo Y	829.54%
Short Float	17.65%
Short Ratio	10.14
Short Shares	9.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-89.1M
Average Volume	306,939.65x
Bv Per Share	8.46
CAPEX	$-318,000
Ch1m	-7.54
Ch1w	-6.45
Ch3m	32.41
Ch6m	24.5
Change	1.87%
Change From Open	-0.39
Close	22.5
Days Gap	2.27
Depreciation Amortization	1,361,000
Dollar Volume	9,477,603.4
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-90M
EBITDA	$-88.6M
EPS	$-5.36
F Score	1
FCF	$-80.4M
FCF EV Yield	-12.91x
FCF Per Share	$-2.23
Financing CF	338,026,000
Fiscal Year End	December
Founded	2,020
Investing CF	-214,166,000
Ipr	43.25
Iprfo	32.87
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-05
Ma20	25.45
Ma20ch	-9.93%
Net CF	43,815,000
Next Earnings Date	2026-08-07
Open	23.01
Optionable	Yes
Position In Range	20.16
Post Close	22.92
Postmarket Change Percent	2.79
Postmarket Price	$23.56
Ppne	9,570,000
Pre Close	22.5
Price Date	2026-05-08
Ptbv Ratio	2.71
Relative Volume	1.35x
Revenue	10,000,000x
SBC By Revenue	87.66x
Share Based Comp	8,766,000
Tr6m	24.5%
Us State	California
Volume	413,508

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EVMN pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns EVMN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+40.1%

Float: +54.4% of shares outstanding

Insider ownership

+2.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

EVMN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.6

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EVMN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current EVMN stock rating?

Evommune, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full EVMN analysis?

The full report lives at /stocks/EVMN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for EVMN?

The latest report frames EVMN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the EVMN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.